Literature DB >> 28786421

Bladder cancer: PPARγ-RXRα alterations promote immune evasion.

Peter Sidaway.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28786421     DOI: 10.1038/nrurol.2017.133

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer.

Authors:  Manav Korpal; Xiaoling Puyang; Zhenhua Jeremy Wu; Roland Seiler; Craig Furman; Htoo Zarni Oo; Michael Seiler; Sean Irwin; Vanitha Subramanian; Jaya Julie Joshi; Chris K Wang; Victoria Rimkunas; Davide Tortora; Hua Yang; Namita Kumar; Galina Kuznetsov; Mark Matijevic; Jesse Chow; Pavan Kumar; Jian Zou; Jacob Feala; Laura Corson; Ryan Henry; Anand Selvaraj; Allison Davis; Kristjan Bloudoff; James Douglas; Bernhard Kiss; Morgan Roberts; Ladan Fazli; Peter C Black; Peter Fekkes; Peter G Smith; Markus Warmuth; Lihua Yu; Ming-Hong Hao; Nicholas Larsen; Mads Daugaard; Ping Zhu
Journal:  Nat Commun       Date:  2017-07-24       Impact factor: 14.919

  1 in total
  1 in total

1.  DEPDC1B is a tumor promotor in development of bladder cancer through targeting SHC1.

Authors:  Chin-Hui Lai; Kexin Xu; Jianhua Zhou; Mingrui Wang; Weiyu Zhang; Xianhui Liu; Jie Xiong; Tao Wang; Qi Wang; Huanrui Wang; Tao Xu; Hao Hu
Journal:  Cell Death Dis       Date:  2020-11-17       Impact factor: 8.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.